ET
SAGE

Entropy Technologies’s Sage Therapeutics SAGE Stock Holding History

Entropy Technologies’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,444
Closed -$112K – 958
2024
Q3 		$112K Sell
15,444
-6,699
-30% -$61.3K 0.01% 676
2024
Q2 		$240K Buy
22,143
+2,900
+15% +$37.2K 0.03% 557
2024
Q1 		$361K Sell
19,243
-17,326
-47% -$400K 0.04% 522
2023
Q4 		$792K Buy
+36,569
New +$725K 0.15% 239

Other funds holding SAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Entropy Technologies's SAGE Position: Q4 2024 in Review

Entropy Technologies sold out of Sage Therapeutics (SAGE) in Q4 2024, closing a stake of 15,444 shares — an estimated $112K sold.

Entropy Technologies first reported a position in SAGE in Q4 2023 and held it in 4 quarters. The position peaked at $792K in Q4 2023. 177 funds tracked by Wall St. Rank hold SAGE as of Q4 2024.

  • Entropy Technologies reported no remaining Sage Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Entropy Technologies sold 15,444 Sage Therapeutics shares in Q4 2024, an estimated $112K.
  • Entropy Technologies first reported a position in Sage Therapeutics in Q4 2023 and held it in 4 quarters.
  • Entropy Technologies's Sage Therapeutics position peaked at $792K in Q4 2023.
  • 177 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2024.

Based on Entropy Technologies's 13F filing for Q4 2024, filed 28 Jan 2025.